Furthermore, a study in osteosarcoma tumours determined that silencing CCN1 reduces tumour vascularisation and slows the growth of osteosarcoma cells resulting in a reduction in subsequent lung metastases [27]. This evidence concerns the gene CCN1 and neoplasm.